Ledger.Open graph →
SEC Form D · filed April 19, 2016

Twist Bioscience Corp

Offering
$2.6M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Solange M. Glaize · San Francisco, CAExecRob M. Chess · San Francisco, CADirectorPaul M. Conley · San Francisco, CADirectorKeith M. Crandell · San Francisco, CADirectorBill M. Peck · San Francisco, CAExecNick J. Naclerio · San Francisco, CADirectorEmily M. Leproust · San Francisco, CAExec · DirectorFred M. Craves · San Francisco, CADirectorWilliam M. Banyai · San Francisco, CAExec · DirectorSam Liebman · New York, NYDirectorJoseph M. Niehaus · San Francisco, CADirectorKirk J. Pulley · PORTLAND, ORExecCarol Levenson · Chicago, ILDirectorJoe P. Nemeth · Redwood City, CADirectorMichael J. Fourticq, Senior · Houston, TXExec · DirectorWilliam N. Anderson · Houston, TXExec · DirectorBritton L. Brown · Dallas, TXDirectorPeter H. Huizenga · Oak Brook, ILExecMark G. Hilderbrand · San Francisco, CADirectorBarry D. Reynolds · San Francisco, CADirectorLisa A. Walker · Carmel, INDirectorStephen P. Bick · Carlsbad, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗